title: Superagonistic CD28 antibody induces donor-specific tolerance in rat renal allografts.
abstract: The ultimate goal of organ transplantation is to establish graft tolerance where CD4+CD25+FOXP3+ regulatory T (Treg) cells play an important role. We examined whether a superagonistic monoclonal antibody specific for CD28 (CD28 SA), which expands Treg cells in vivo, would prevent acute rejection and induce tolerance using our established rat acute renal allograft model (Wistar to Lewis). In the untreated or mouse IgG-treated recipients, graft function significantly deteriorated with marked destruction of renal tissue, and all rats died by 13 days with severe azotemia. In contrast, 90% of recipients treated with CD28 SA survived over 100 days, and 70% survived with well-preserved graft function until graft recovery at 180 days. Analysis by flow cytometry and immunohistochemistry demonstrated that CD28 SA induced marked infiltration of FOXP3+ Treg cells into the allografts. Furthermore, these long-surviving recipients showed donor-specific tolerance, accepting secondary (donor-matched) Wistar cardiac allografts, but acutely rejecting third-party BN allografts. We further demonstrated that adoptive transfer of CD4+CD25+ Treg cells, purified from CD28 SA-treated Lewis rats, significantly prolonged allograft survival and succeeded in inducing donor-specific tolerance. In conclusion, CD28 SA treatment successfully induces donor-specific tolerance with the involvement of Treg cells, and thus the therapeutic value of this approach warrants further investigation and preclinical studies.
authors: Department of Urology, Osaka Medical College, Takatsuki, Osaka, Japan.
authors: H
authors: H
authors: Azuma
authors: Y
authors: Y
authors: Isaka
authors: X
authors: X
authors: Li
authors: T
authors: T
authors: Hünig
authors: T
authors: T
authors: Sakamoto
authors: H
authors: H
authors: Nohmi
authors: Y
authors: Y
authors: Takabatake
authors: M
authors: M
authors: Mizui
authors: Y
authors: Y
authors: Kitazawa
authors: N
authors: N
authors: Ichimaru
authors: N
authors: N
authors: Ibuki
authors: T
authors: T
authors: Ubai
authors: T
authors: T
authors: Inamoto
authors: Y
authors: Y
authors: Katsuoka
authors: S
authors: S
authors: Takahara
mesh_terms: D000818:Animals; D018106:CD28 Antigens / Q000737:chemistry / Q000276:immunology*; D015496:CD4-Positive T-Lymphocytes / Q000378:metabolism; D005434:Flow Cytometry / Q000379:methods; D051858:Forkhead Transcription Factors / Q000096:biosynthesis; D006085:Graft Survival; D007108:Immune Tolerance / Q000276:immunology*; D007074:Immunoglobulin G / Q000378:metabolism; D007150:Immunohistochemistry / Q000379:methods; D053645:Interleukin-2 Receptor alpha Subunit / Q000096:biosynthesis; D016030:Kidney Transplantation / Q000379:methods*; D008297:Male; D051379:Mice; D051381:Rats; D011917:Rats, Inbred Lew; D017208:Rats, Wistar; D050378:T-Lymphocytes, Regulatory / Q000276:immunology
chemical_list: D018106:CD28 Antigens; D051858:Forkhead Transcription Factors; C500522:Foxp3 protein, rat; D007074:Immunoglobulin G; D053645:Interleukin-2 Receptor alpha Subunit